Fine Daniel H, Markowitz Kenneth, Furgang David, Fairlie Karen, Ferrandiz Javier, Nasri Cebile, McKiernan Marie, Gunsolley John
Department of Oral Biology, University of Medicine and Dentistry of New Jersey, Newark, NJ 07101, USA.
J Clin Microbiol. 2007 Dec;45(12):3859-69. doi: 10.1128/JCM.00653-07. Epub 2007 Oct 17.
Aggregatibacter actinomycetemcomitans is frequently associated with localized aggressive periodontitis (LAP); however, longitudinal cohort studies relating A. actinomycetemcomitans to initiation of LAP have not been reported. A periodontal assessment was performed on 1,075 primarily African-American and Hispanic schoolchildren, ages 11 to 17 years. Samples were taken from each child for A. actinomycetemcomitans. A cohort of 96 students was established that included a test group of 38 A. actinomycetemcomitans-positive students (36 periodontally healthy and 2 with periodontal pockets) and 58 healthy A. actinomycetemcomitans-negative controls. All clinical and microbiological procedures were repeated at 6-month intervals. Bitewing radiographs were taken annually for definitive diagnosis of LAP. At the initial examination, clinical probing attachment measurements indicated that 1.2% of students had LAP, while 13.7% carried A. actinomycetemcomitans, including 16.7% of African-American and 11% of Hispanic students (P = 0.001, chi-square test). A. actinomycetemcomitans serotypes a, b, and c were equally distributed among African-Americans; Hispanic students harbored predominantly serotype c (P = 0.05, chi-square test). In the longitudinal phase, survival analysis was performed to determine whether A. actinomycetemcomitans-positive as compared to A. actinomycetemcomitans-negative students remained healthy ("survived") or progressed to disease with attachment loss of >2 mm or bone loss (failed to "survive"). Students without A. actinomycetemcomitans at baseline had a significantly greater chance to remain healthy (survive) compared to the A. actinomycetemcomitans-positive test group (P = 0.0001). Eight of 38 A. actinomycetemcomitans-positive and none of 58 A. actinomycetemcomitans-negative students showed bone loss (P = 0.01). A. actinomycetemcomitans serotype did not appear to influence survival. These findings suggest that detection of A. actinomycetemcomitans in periodontally healthy children can serve as a risk marker for initiation of LAP.
伴放线聚集杆菌常与局限性侵袭性牙周炎(LAP)相关;然而,尚未有关于伴放线聚集杆菌与LAP发病关系的纵向队列研究报道。对1075名年龄在11至17岁、主要为非裔美国人和西班牙裔的学童进行了牙周评估。从每个孩子身上采集样本检测伴放线聚集杆菌。建立了一个96名学生的队列,其中包括一个由38名伴放线聚集杆菌阳性学生组成的测试组(36名牙周健康,2名有牙周袋)和58名伴放线聚集杆菌阴性的健康对照组。所有临床和微生物学检查每6个月重复一次。每年拍摄咬翼片以明确诊断LAP。在初次检查时,临床探诊附着水平测量表明,1.2%的学生患有LAP,而13.7%的学生携带伴放线聚集杆菌,其中非裔美国学生占16.7%,西班牙裔学生占11%(卡方检验,P = 0.001)。伴放线聚集杆菌血清型a、b和c在非裔美国人中分布均匀;西班牙裔学生主要携带血清型c(卡方检验,P = 0.05)。在纵向研究阶段,进行生存分析以确定与伴放线聚集杆菌阴性学生相比,伴放线聚集杆菌阳性学生是否保持健康(“存活”)或进展为附着丧失>2 mm或骨质丧失的疾病(“未存活”)。与伴放线聚集杆菌阳性测试组相比,基线时无伴放线聚集杆菌的学生保持健康(存活)的机会显著更大(P = 0.0001)。38名伴放线聚集杆菌阳性学生中有8名出现骨质丧失,而58名伴放线聚集杆菌阴性学生中无一例出现骨质丧失(P = 0.01)。伴放线聚集杆菌血清型似乎不影响生存。这些发现表明,在牙周健康儿童中检测到伴放线聚集杆菌可作为LAP发病的风险标志物。